NFAT3 Antibody [H15F22]

N.º de catálogo F4697

Imprimir

Descripción biológica

Especificidad NFAT3 Antibody [H15F22] detecta niveles endógenos de proteína NFAT3 total.
Antecedentes NFAT3 (NFATc4), un factor de transcripción de la familia de factores nucleares de células T activadas (NFAT) predominantemente expresado en células T, células B y miocitos cardíacos, contiene un dominio regulador N-terminal intrínsecamente desordenado con regiones ricas en serina (SRR) y motivos repetidos SP que sirven como sitios de acoplamiento de calcineurina, una región central de homología Rel (RHR) con un pliegue similar a una inmunoglobulina con un dominio de unión a ADN que reconoce secuencias consenso GGAAA y una señal de localización nuclear (NLS), y un dominio de transactivación C-terminal (TAD) que recluta coactivadores CBP/p300. Tras la estimulación del receptor de células T (TCR) o GPCR, el aumento de Ca2+ citosólico activa la calcineurina unida a calmodulina, que desfosforila 14 residuos de serina conservados en las regiones SRR/SP, exponiendo el NLS y permitiendo la translocación nuclear de NFAT3. En el núcleo, NFAT3 se homodimeriza o coopera con socios como AP-1 (c-Fos/c-Jun), GATA3 o MEF2 para transactivar genes de citoquinas (IL-2, IL-4, TNF-α) y FasL en sitios NFAT:AP-1 compuestos, mientras que en los cardiomiocitos, impulsa la hipertrofia patológica al inducir la expresión génica de BNP y MHCα. La exportación nuclear y la secuestración citoplasmática se restauran mediante la refosforilación a través de GSK3β, CK1 o PKA. De manera única, NFAT3 reprime la progresión del ciclo celular y promueve la apoptosis en neuronas a través de la inducción de Trim17, en contraste con el papel pro-muerte de NFAT4; la deficiencia de NFAT3 afecta la diferenciación Th2 y las respuestas de IgE. La hiperactivación nuclear desregulada de NFAT3 contribuye a la inflamación sinovial de la artritis reumatoide, la hipertrofia y la insuficiencia cardíaca bajo sobrecarga de presión, y los linfomas de células B a través de la señalización constitutiva de IL-2.

Información de uso

Aplicación WB Dilución
WB
1:1000
Reactividad Human, Mouse, Rat
Fuente Rabbit Monoclonal Antibody MW 120-140 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/9143705/
  • https://pubmed.ncbi.nlm.nih.gov/27100893/

Datos de aplicación

WB

Validado por Selleck

  • F4697-wb
    Lane 1: A204, Lane 2: A10, Lane 3: Hela